GSK, which developed and sold versions of the now-discontinued blockbuster heartburn drug, agreed to pay up to $2.2 billion.
Zantac’s Developer Settles Lawsuits Claiming Cancer Link
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Facebook
Twitter
LinkedIn
Pinterest
Pocket
WhatsApp
Never miss any important news. Subscribe to our newsletter.
Never miss any important news. Subscribe to our newsletter.
Recent News
Investor discusses impact of elevated interest rates on real estate
December 3, 2024
What’s Next for Google’s Search Monopoly
December 3, 2024
Jon Stewart Thinks Biden Could Have Timed That Pardon Better
December 3, 2024
Pardoning Hunter Complicates the Legacy That Biden Envisioned
December 3, 2024
After Biden Pardons His Son, Prison Inmates Hope They’re Next
December 3, 2024
Trump Says He Will Block Nippon Steel’s Acquisition of U.S. Steel
December 3, 2024